Legis Daily

Lowering Costs by Improving Biosimilar Uptake Act

USA117th CongressHR-7047| House 
| Updated: 3/10/2022
Kurt Schrader

Kurt Schrader

Democratic Representative

Oregon

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Lowering Costs by Improving Biosimilar Uptake Act This bill allows for the omission of certain information relating to the strength of a product in a biosimilar application, as determined by the Food and Drug Administration.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 9, 2022
Introduced in House
Mar 9, 2022
Referred to the House Committee on Energy and Commerce.
Mar 10, 2022
Referred to the Subcommittee on Health.
  • March 9, 2022
    Introduced in House
  • March 9, 2022
    Referred to the House Committee on Energy and Commerce.
  • March 10, 2022
    Referred to the Subcommittee on Health.

Health

Lowering Costs by Improving Biosimilar Uptake Act

USA117th CongressHR-7047| House 
| Updated: 3/10/2022
Lowering Costs by Improving Biosimilar Uptake Act This bill allows for the omission of certain information relating to the strength of a product in a biosimilar application, as determined by the Food and Drug Administration.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 9, 2022
Introduced in House
Mar 9, 2022
Referred to the House Committee on Energy and Commerce.
Mar 10, 2022
Referred to the Subcommittee on Health.
  • March 9, 2022
    Introduced in House
  • March 9, 2022
    Referred to the House Committee on Energy and Commerce.
  • March 10, 2022
    Referred to the Subcommittee on Health.
Kurt Schrader

Kurt Schrader

Democratic Representative

Oregon

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted